Abstract
Diarrhoea remains one of the top three causes of death in Africa. However, data on the molecular epidemiology of enteric viruses in Nigeria is rare.
Two hundred and forty three infants and children below the age of 5 years with acute watery diarrhoea were evaluated for the presence of enteric viruses in stool by real-time PCR (rtPCR) during the dry months of December to April 2017, which correspond to diarrhoea season in South-East Nigeria. At least one viral pathogen was detected in 95.1% (231/243) of the study population. Rotavirus, 231(95.1%) was the most common followed by adenovirus, 103(42.4%) and enterovirus 32(13.2%). Other viruses seen in the stool samples include astrovirus 7.3 % (11/151), parechovirus 3.5 % (4/113), sapovirus, 2.8 % (4/145), bocavirus 6.8% (5/73) and human coronavirus 13.9% (10/73). Norovirus and hepatitis A and E viruses were not detected. Children that consumed factory packaged water had the lowest prevalence of rotavirus infection (p=0.044). A significant association between the viral pathogen and home treatment of drinking water or exclusive breastfeeding was not observed. Randomly selected 46 samples were genotyped for rotavirus, which showed that G3P[6] (39.1%) was the most common, followed by G1P[8] (15.2%), G9P[8] (13.0%), G12P[8] (6.5%), G9P[6]P[8] (2.2%), and G12P[6] (2.2%).
This was the highest rotavirus prevalence in any published African study, and may be a reflection of inadequate water sanitation/hygiene in the study area, a peculiar epidemiological situation and/or the sensitivity of the diagnostic method used.
The present study suggests that the burden of rotavirus is bigger than previously reported; and that morbidity can be greatly reduced if rotavirus vaccine is included in Nigerian national immunization policy.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This project was funded by personal contribution from all authors
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Not Applicable
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Thia project was approved by the Ethical committee of Alex Ekweme Federal University Teaching Hospital, Abakaliki, Nigeria
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Not Applicable
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Not Applicable
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Not Applicable
Data Availability
Sample of the questionnaire used for data collection will be made available
